Brief: Clovis Oncology Announces Q1 Loss Per Share Of $0.64
05/05/2021 13:16
May 5 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY ANNOUNCES FIRST QUARTER 2021 OPERATING
RESULTS
* Q1 LOSS PER SHARE $0.64
* QUARTERLY PRODUCT REVENUE $38.1 MILLION VERSUS $42.6
MILLION
Source text for Eikon: ID:nBw9XmkYma
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber